PBH
Prestige Consumer Healthcare Inc.
NYSE · Healthcare · Medical - Distribution · US
$44.97
−3.23%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.06
- Revenue estimate
- $326.2M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.98
- EPS estimate
- $0.90
- Revenue actual
- $265.7M
- Revenue estimate
- $252.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +1.6%
- Revenue beats (12Q)
- 3
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.90 | $0.98 | Beat 9.50% | $265.7M |
| May 14, 2026 | $1.39 | $1.23 | Miss -11.51% | $281.6M |
| Mar 19, 2026 | $1.16 | $1.14 | Miss -1.72% | $283.4M |
| Nov 6, 2025 | $0.97 | $1.07 | Beat 10.31% | $274.1M |
| Aug 7, 2025 | $1.01 | $0.95 | Miss -5.94% | $249.5M |
| May 8, 2025 | $1.30 | $1.32 | Beat 1.54% | $296.8M |
| Feb 6, 2025 | $1.16 | $1.22 | Beat 5.17% | $290.3M |
| Nov 7, 2024 | $1.08 | $1.09 | Beat 0.93% | $283.5M |
| Aug 8, 2024 | $0.86 | $0.90 | Beat 4.65% | $267.1M |
| Feb 8, 2024 | $1.04 | $1.06 | Beat 1.83% | $282.7M |
| Nov 2, 2023 | $1.07 | $1.07 | In line | $286.3M |
| Aug 3, 2023 | $1.01 | $1.06 | Beat 4.74% | $279.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026